Last updated: 8 July 2024 at 4:03pm EST

Dr. Jane Edna Huang M.D. Net Worth




The estimated Net Worth of Jane Huang is at least $23.7 Million dollars as of 4 July 2024. Dr Huang owns over 9,375 units of BeiGene Ltd stock worth over $12,808,781 and over the last 8 years he sold BGNE stock worth over $10,169,145. In addition, he makes $705,488 as Chief Medical Officer of Hematology at BeiGene Ltd.

Dr D BGNE stock SEC Form 4 insiders trading

Dr has made over 52 trades of the BeiGene Ltd stock since 2017, according to the Form 4 filled with the SEC. Most recently he exercised 9,375 units of BGNE stock worth $1,979,531 on 4 July 2024.

The largest trade he's ever made was exercising 37,500 units of BeiGene Ltd stock on 4 April 2023 worth over $7,918,125. On average, Dr trades about 3,846 units every 36 days since 2016. As of 4 July 2024 he still owns at least 60,662 units of BeiGene Ltd stock.

You can see the complete history of Dr Huang stock trades at the bottom of the page.





Dr. Jane Edna Huang M.D. biography

Dr. Jane Edna Huang M.D. is the Chief Medical Officer of Hematology at BeiGene Ltd.

What is the salary of Dr D?

As the Chief Medical Officer of Hematology of BeiGene Ltd, the total compensation of Dr D at BeiGene Ltd is $705,488. There are 7 executives at BeiGene Ltd getting paid more, with John Oyler having the highest compensation of $13,899,000.



How old is Dr D?

Dr D is 47, he's been the Chief Medical Officer of Hematology of BeiGene Ltd since . There are 16 older and 3 younger executives at BeiGene Ltd. The oldest executive at BeiGene Ltd is Donald Glazer, 75, who is the Non-Executive Independent Director.

What's Dr D's mailing address?

Jane's mailing address filed with the SEC is C/O PRELUDE THERAPEUTICS INCORPORATED, 175 INNOVATION BOULEVARD, WILMINGTON, DE, 19805.

Insiders trading at BeiGene Ltd

Over the last 9 years, insiders at BeiGene Ltd have traded over $1,899,158,980 worth of BeiGene Ltd stock and bought 23,241,738 units worth $1,040,248,444 . The most active insiders traders include Bros. Advisors Lp667, L.P.B..., Investment Management, Ltd...., and Bros. Advisors Lp Baker Bro.... On average, BeiGene Ltd executives and independent directors trade stock every 13 days with the average trade being worth of $33,382,815. The most recent stock trade was executed by Xiaobin Wu on 3 September 2024, trading 5,556 units of BGNE stock currently worth $1,053,695.



What does BeiGene Ltd do?

BeiGene is a biotechnology company that specializes in the development of drugs for cancer treatment. BeiGene has developed several pharmaceuticals, including tislelizumab, a checkpoint inhibitor, and zanubrutinib.



What does BeiGene Ltd's logo look like?

BeiGene Ltd logo

Complete history of Dr Huang stock trades at BeiGene Ltd, Protara Therapeutics Inc, and Prelude Therapeutics Inc

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
4 Jul 2024 Jane Huang
President and CMO
Option 9,375 $3.62 $33,938
4 Jul 2024
60,662
4 Apr 2024 Jane Huang
President and CMO
Option 9,375 $4.74 $44,438
4 Apr 2024
54,634
4 Jan 2024 Jane Huang
President and CMO
Option 9,375 $3.92 $36,750
4 Jan 2024
49,103
4 Oct 2023 Jane Huang
President and CMO
Option 9,375 $2.69 $25,219
4 Oct 2023
39,728
4 Jul 2023 Jane Huang
President and CMO
Option 9,375 $4.52 $42,375
4 Jul 2023
33,595
4 Apr 2023 Jane Huang
President and CMO
Option 37,500 $6.06 $227,250
4 Apr 2023
37,500
14 Dec 2021 Jane Huang
CMO and Hematology
Option 1,500 $119.96 $179,940
14 Dec 2021
1,500
30 Nov 2021 Jane Huang
CMO and Hematology
Sale 1,049 $359.86 $377,493
30 Nov 2021
0
17 Nov 2021 Jane Huang
CMO and Hematology
Option 1,500 $119.96 $179,940
17 Nov 2021
1,500
19 Oct 2021 Jane Huang
CMO and Hematology
Option 1,500 $119.96 $179,940
19 Oct 2021
1,500
20 Sep 2021 Jane Huang
CMO and Hematology
Option 6,000 $119.96 $719,760
20 Sep 2021
6,000
13 Sep 2021 Jane Huang
CMO and Hematology
Sale 12,901 $358.14 $4,620,364
13 Sep 2021
0
31 Aug 2021 Jane Huang
CMO and Hematology
Sale 1,087 $318.88 $346,623
31 Aug 2021
0
15 Jul 2021 Jane Huang
CMO and Hematology
Option 21,000 $146.90 $3,084,900
15 Jul 2021
21,000
28 Jun 2021 Jane Huang
CMO and Hematology
Sale 1,925 $354.97 $683,317
28 Jun 2021
0
16 Jun 2021 Jane Huang
CMO and Hematology
Sale 469 $325.66 $152,735
16 Jun 2021
0
7 Jun 2021 Jane Huang
CMO and Hematology
Sale 603 $351.55 $211,985
7 Jun 2021
0
28 May 2021 Jane Huang
CMO and Hematology
Sale 2,040 $357.98 $730,279
28 May 2021
0
29 Apr 2021 Jane Huang
CMO and Hematology
Option 1,500 $29.49 $44,235
29 Apr 2021
1,500
29 Mar 2021 Jane Huang
CMO and Hematology
Option 1,500 $29.49 $44,235
29 Mar 2021
1,500
26 Feb 2021 Jane Huang
CMO and Hematology
Option 1,500 $29.49 $44,235
26 Feb 2021
1,500
29 Jan 2021 Jane Huang
CMO and Hematology
Option 1,500 $29.49 $44,235
29 Jan 2021
1,500
29 Dec 2020 Jane Huang
CMO and Hematology
Option 1,500 $29.49 $44,235
29 Dec 2020
1,500
30 Nov 2020 Jane Huang
CMO and Hematology
Option 1,500 $29.49 $44,235
30 Nov 2020
1,500
29 Oct 2020 Jane Huang
CMO and Hematology
Option 1,500 $29.49 $44,235
29 Oct 2020
1,500
29 Sep 2020 Jane Huang
CMO and Hematology
Option 1,500 $29.49 $44,235
29 Sep 2020
1,500
3 Sep 2020 Jane Huang
CMO and Hematology
Sale 3,128 $233.07 $729,043
3 Sep 2020
0
28 Aug 2020 Jane Huang
CMO and Hematology
Option 3,000 $29.49 $88,470
28 Aug 2020
3,000
29 Jul 2020 Jane Huang
CMO and Hematology
Option 3,000 $94.95 $284,850
29 Jul 2020
3,000
7 Jul 2020 Jane Huang
CMO and Hematology
Option 3,921 $160.40 $628,928
7 Jul 2020
3,921
26 Jun 2020 Jane Huang
CMO and Hematology
Sale 4,014 $195.73 $785,660
26 Jun 2020
0
8 Jun 2020 Jane Huang
CMO and Hematology
Sale 631 $170.84 $107,800
8 Jun 2020
0
29 May 2020 Jane Huang
CMO and Hematology
Option 1,500 $29.49 $44,235
29 May 2020
1,500
29 Apr 2020 Jane Huang
CMO and Hematology
Option 1,500 $29.49 $44,235
29 Apr 2020
1,500
16 Apr 2020 Jane Huang
CMO and Hematology
Option 1,500 $29.49 $44,235
16 Apr 2020
1,500
18 Feb 2020 Jane Huang
CMO and Hematology
Option 1,500 $29.49 $44,235
18 Feb 2020
1,500
21 Jan 2020 Jane Huang
CMO and Hematology
Option 1,500 $29.49 $44,235
21 Jan 2020
1,500
16 Dec 2019 Jane Huang
CMO and Hematology
Option 1,500 $29.49 $44,235
16 Dec 2019
1,500
18 Nov 2019 Jane Huang
CMO and Hematology
Option 1,500 $29.49 $44,235
18 Nov 2019
1,500
4 Nov 2019 Jane Huang
CMO and Hematology
Option 32,900 $29.49 $970,221
4 Nov 2019
32,900
3 Sep 2019 Jane Huang
CMO and Hematology
Sale 2,944 $144.03 $424,024
3 Sep 2019
0
12 Aug 2019 Jane Huang
CMO and Hematology
Option 2,500 $45.31 $113,275
12 Aug 2019
2,500
29 Jul 2019 Jane Huang
CMO and Hematology
Option 10,130 $37.30 $377,849
29 Jul 2019
10,130
27 Jun 2019 Jane Huang
CMO and Hematology
Sale 430 $124.52 $53,544
27 Jun 2019
0
20 May 2019 Jane Huang
CMO and Hematology
Option 2,500 $45.31 $113,275
20 May 2019
2,200
8 Apr 2019 Jane Huang
CMO and Hematology
Option 14,130 $29.49 $416,694
8 Apr 2019
14,130
7 Mar 2019 Jane Huang
CMO and Hematology
Sale 2,636 $130.28 $343,418
7 Mar 2019
0
26 Nov 2018 Jane Huang
CMO and Hematology
Option 3,000 $29.49 $88,470
26 Nov 2018
3,000
4 Sep 2018 Jane Huang
CMO and Hematology
Sale 2,911 $174.60 $508,261
4 Sep 2018
0
21 Dec 2017 Jane Huang
CMO and Hematology
Option 1,000 $29.51 $29,510
21 Dec 2017
1,000
13 Dec 2017 Jane Huang
CMO and Hematology
Option 1,500 $29.51 $44,265
13 Dec 2017
1,500
4 Dec 2017 Jane Huang
CMO and Hematology
Sale 1,100 $86.00 $94,600
4 Dec 2017
0


BeiGene Ltd executives and stock owners

BeiGene Ltd executives and other stock owners filed with the SEC include: